Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 6,177: | Line 6,177: | ||
"title" : "Telmisartan, ramipril, or both in patients at high risk for vascular events", | "title" : "Telmisartan, ramipril, or both in patients at high risk for vascular events", | ||
"pmid" : "18378520" | "pmid" : "18378520" | ||
}, | |||
{ | |||
"timestamp" : "2025-05-16T15:04:11Z", | |||
"briefDesignDescription" : "LAA closure vs. anticoagulation in AF", | |||
"fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa2408308", | |||
"pageid" : 5693, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2408308", | |||
"trainingLevel" : "Student", | |||
"citation" : "Wazni OM, <i>et al</i>. \"Left atrial appendage closure after ablation for atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2025. 392(13):1277-1287.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "cOmParison of anTIcoagulation with left atrial appendage clOsure after atrial fibrillation ablatioN", | |||
"statusUsableDate" : "2025-04-20", | |||
"briefResultsDescription" : "LAA closure non-inferior or superior for AF outcomes vs. anticoagulation", | |||
"published" : "2025-04-03", | |||
"pageName" : "OPTION", | |||
"diseases" : "Atrial Fibrillation", | |||
"abbreviation" : "OPTION", | |||
"title" : "Left atrial appendage closure after ablation for atrial fibrillation", | |||
"pmid" : "39555822" | |||
}, | }, | ||
{ | { |